bioAffinity Technologies, Inc. Stock
Equities
BIAF
US09076W1099
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.02 USD | -2.42% | -11.79% | +37.37% |
Financials (USD)
Sales 2022 | 0 | Sales 2023 | 2.53 | Capitalization | 13.97M |
---|---|---|---|---|---|
Net income 2022 | -8M | Net income 2023 | -7M | EV / Sales 2022 | 464,207,162 x |
Net cash position 2022 | 11.16M | Net cash position 2023 | 1.24M | EV / Sales 2023 | 5,026,702 x |
P/E ratio 2022 |
-0.88
x | P/E ratio 2023 |
-1.62
x | Employees | 14 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 64.96% |
Latest transcript on bioAffinity Technologies, Inc.
1 day | -2.42% | ||
1 week | -11.79% | ||
Current month | -17.55% | ||
1 month | -22.61% | ||
3 months | +27.85% | ||
6 months | +36.49% | ||
Current year | +37.37% |
Managers | Title | Age | Since |
---|---|---|---|
Maria Zannes
FOU | Founder | 68 | 14-03-25 |
Director of Finance/CFO | 45 | 23-04-30 | |
David Elzi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Girgenti
CHM | Chairman | 78 | 14-02-28 |
Peter Knight
BRD | Director/Board Member | 73 | 18-04-30 |
Stuart Diamond
BRD | Director/Board Member | 63 | 21-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 2.07 | -0.48% | 43,641 |
24-05-07 | 2.08 | +5.58% | 87,405 |
24-05-06 | 1.97 | -5.74% | 150,127 |
24-05-03 | 2.09 | -8.73% | 116,956 |
24-05-02 | 2.29 | -6.53% | 107,813 |
Delayed Quote Nasdaq, May 09, 2024 at 04:30 pm EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+37.37% | 23.83M | |
-1.34% | 12.58B | |
-1.64% | 8.51B | |
+0.09% | 5.29B | |
+22.42% | 5.16B | |
-0.09% | 4.55B | |
-52.84% | 3.04B | |
+20.02% | 3B | |
+31.92% | 2.17B | |
-2.45% | 1.92B |
- Stock Market
- Equities
- BIAF Stock